AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+38.55%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.94B
AUM Growth
+$2.94B
(+40%)
Cap. Flow
-$16M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
47.94%
Holding
134
New
28
Increased
21
Reduced
57
Closed
5
Top Buys
| 1 |
GDS Holdings
GDS
|
$87.6M |
| 2 |
Generation Bio
GBIO
|
$59.1M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$37.7M |
| 4 |
Royalty Pharma
RPRX
|
$36.4M |
| 5 |
NovaGold Resources
NG
|
$23.9M |
Top Sells
| 1 |
Moderna
MRNA
|
$161M |
| 2 |
Avantor
AVTR
|
$42.5M |
| 3 |
PayPal
PYPL
|
$41.8M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$29.6M |
| 5 |
Zillow
Z
|
$24M |
Sector Composition
| 1 | Healthcare | 75.63% |
| 2 | Consumer Discretionary | 16.28% |
| 3 | Technology | 3.84% |
| 4 | Financials | 1.19% |
| 5 | Communication Services | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
AC Immune
ACIU
$205M
| $6.63M | 0.19% | 984,550 -15,450 | -2% | -$104K |
|
|
APTX
77
DELISTED
Aptinyx Inc. Common Stock
APTX
| $6.59M | 0.18% | 1,581,090 -85,576 | -5% | -$357K |
|
|
AUTL
78
Autolus Therapeutics
AUTL
$399M
| $6.41M | 0.18% | 400,000 -100,000 | -20% | -$1.6M |
|
79
Passage Bio
PASG
$22.7M
| $6.4M | 0.18% | 234,000 -16,000 | -6% | -$437K |
|
80
ADC Therapeutics
ADCT
$345M
| $6.37M | 0.18% | +136,000 | New | +$6.37M |
|
81
Leap Therapeutics
LPTX
$12M
| $6.22M | 0.17% | 2,974,000 +2,724,000 | +1,090% | +$5.69M |
|
82
Merus
MRUS
$4.98B
| $6.18M | 0.17% | 384,000 -116,000 | -23% | -$1.87M |
|
83
Huazhu Hotels Group
HTHT
$11.3B
| $6.13M | 0.17% | +175,000 | New | +$6.13M |
|
84
Nektar Therapeutics
NKTR
$568M
| $5.54M | 0.15% | +239,000 | New | +$5.54M |
|
|
PRVL
85
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $5.51M | 0.15% | 370,000 +170,000 | +85% | +$2.53M |
|
|
TCRR
86
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $5.38M | 0.15% | 350,000 -50,000 | -13% | -$768K |
|
87
Solid Biosciences
SLDB
$427M
| $5.27M | 0.15% | 1,800,000 | – | – |
|
|
SYRS
88
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $5.22M | 0.15% | 490,000 -16,138 | -3% | -$172K |
|
89
Oric Pharmaceuticals
ORIC
$994M
| $5.06M | 0.14% | +150,000 | New | +$5.06M |
|
90
Intellia Therapeutics
NTLA
$1.22B
| $5.02M | 0.14% | +239,000 | New | +$5.02M |
|
|
AXLA
91
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $4.98M | 0.14% | 900,000 +300,000 | +50% | +$1.66M |
|
92
Avidity Biosciences
RNA
$5.99B
| $4.95M | 0.14% | +175,000 | New | +$4.95M |
|
93
Alector
ALEC
$238M
| $4.89M | 0.14% | 200,000 -50,000 | -20% | -$1.22M |
|
94
Zentalis Pharmaceuticals
ZNTL
$122M
| $4.42M | 0.12% | +92,000 | New | +$4.42M |
|
|
YI
95
111 Inc
YI
$55.7M
| $4.13M | 0.12% | 650,000 | – | – |
|
96
Prothena Corp
PRTA
$441M
| $3.87M | 0.11% | 370,000 +70,000 | +23% | +$732K |
|
|
KLDO
97
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $3.72M | 0.1% | 500,500 | – | – |
|
98
IDEAYA Biosciences
IDYA
$2.15B
| $3.4M | 0.1% | +239,304 | New | +$3.4M |
|
99
Dianthus Therapeutics
DNTH
$759M
| $3.38M | 0.09% | +450,000 | New | +$3.38M |
|
|
EVLO
100
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $3.27M | 0.09% | +666,666 | New | +$3.27M |
|